Suppr超能文献

一项关于针刺疗法与最佳药物疗法预防发作性偏头痛的随机临床试验:ACUMIGRAN研究。

A Randomized Clinical Trial on Acupuncture Versus Best Medical Therapy in Episodic Migraine Prophylaxis: The ACUMIGRAN Study.

作者信息

Giannini Giulia, Favoni Valentina, Merli Elena, Nicodemo Marianna, Torelli Paola, Matrà Annunzio, Giovanardi Carlo Maria, Cortelli Pietro, Pierangeli Giulia, Cevoli Sabina

机构信息

Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy.

IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

出版信息

Front Neurol. 2021 Jan 15;11:570335. doi: 10.3389/fneur.2020.570335. eCollection 2020.

Abstract

A large corpus of evidence has reported encouraging results for acupuncture as a prophylaxis therapy for migraine. However, trials that investigated the efficacy of acupuncture in comparison with pharmacological treatment in episodic migraine showed conflicting results. The study aimed to evaluate if acupuncture is as effective as evidence-based pharmacological drugs in episodic migraine prophylaxis. This is a randomized controlled clinical study. Patients suffering from migraine without preventive treatment in the past 3 months were recruited. After the run-in period, episodic migraineurs were assigned randomly to two groups: the acupuncture group (A) was treated with 12 sessions of acupuncture, and the pharmacological group (B) was treated with the most appropriate medication for each patient. Headache frequency was compared at baseline and at the end of treatment. Both groups were evaluated 3 and 6 months after treatment. A total of 148 patients (24 males and 124 females) were enrolled in the study. Out of these, 69 were randomized to A and 66 to B. At baseline, no significant differences were found between the two groups. Of the patients, 15.5% (21/135) interrupted the treatment, especially those randomized to B. After 4 months, migraine frequency decreased from 8.58 ± 3.21 to 6.43 ± 3.45 in A and from 8.29 ± 2.72 to 6.27 ± 4.01 in B. Headache frequency decreased significantly after treatment without differences between the two groups (time-effect: < 0.001; group effect: = 0.332; interaction time-group effects: = 0.556). Approximately 34% of patients showed a reduction of headache days by at least 50% after the treatment. The improvements observed at the end of treatment persisted in 57.3% (59/103) after 3 months and 38.8% (40/103) after 6 months, especially in patients randomized to A. Our trial is the first one comparing acupuncture with the more appropriate pharmacological treatment for migraine prophylaxis. Data suggested that acupuncture could be adopted as migraine prophylaxis and seem to be slightly superior to pharmacological treatment in compliance and rate of adverse events.

摘要

大量证据表明,针灸作为偏头痛的预防疗法取得了令人鼓舞的效果。然而,比较针灸与药物治疗在发作性偏头痛中疗效的试验结果却相互矛盾。本研究旨在评估在发作性偏头痛预防中,针灸是否与循证药理学药物一样有效。这是一项随机对照临床研究。招募过去3个月内未接受预防性治疗的偏头痛患者。在导入期后,发作性偏头痛患者被随机分为两组:针灸组(A组)接受12次针灸治疗,药物组(B组)接受针对每位患者的最合适药物治疗。比较基线期和治疗结束时的头痛频率。两组在治疗后3个月和6个月进行评估。共有148例患者(24例男性和124例女性)纳入研究。其中,69例随机分配至A组,66例随机分配至B组。基线期,两组间未发现显著差异。患者中,15.5%(21/135)中断治疗,尤其是随机分配至B组的患者。4个月后,A组偏头痛频率从8.58±3.21降至6.43±3.45,B组从8.29±2.72降至6.27±4.01。治疗后头痛频率显著降低,两组间无差异(时间效应:<0.001;组效应:=0.332;时间-组交互效应:=0.556)。约34%的患者治疗后头痛天数减少至少50%。治疗结束时观察到的改善在3个月后持续存在于57.3%(59/103)的患者中,6个月后持续存在于38.8%(40/103)的患者中,尤其是随机分配至A组的患者。我们的试验是首个比较针灸与更合适的偏头痛预防药物治疗的研究。数据表明,针灸可作为偏头痛预防方法,在依从性和不良事件发生率方面似乎略优于药物治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6fc/7843562/85acbd7a421e/fneur-11-570335-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验